702 results on '"Ieiri, Ichiro"'
Search Results
2. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation
3. Eye-tracking-based analysis of pharmacists’ thought processes in the dispensing work: research related to the efficiency in dispensing based on right-brain thinking
4. Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes
5. Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system
6. Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance
7. Population Pharmacokinetic Analysis of Drug–Drug Interactions Between Perampanel and Carbamazepine Using Enzyme Induction Model in Epileptic Patients
8. Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406
9. Simplified daptomycin dosing regimen for adult patients with methicillin-resistant Staphylococcus aureus infections based on population pharmacokinetic analysis
10. Analysis of the thinking process of pharmacists in response to changes in the dispensing environment using the eye-tracking method
11. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats
12. Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study
13. Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study
14. Risk Factors of Cetuximab-Induced Hypomagnesemia and the Effect of Magnesium Prophylaxis in Patients with Head and Neck Cancer: A Retrospective Study
15. Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis
16. Factors Influencing Serum Posaconazole Concentrations in Patients With Hematologic Malignancies Receiving Delayed-Release Tablets
17. Effect of Genetic Polymorphisms of Human SLC22A3 in the 5’-flanking Region on OCT3 Expression and Sebum Levels in Human Skin
18. Interindividual variability in statin pharmacokinetics and effects of drug transporters
19. Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma
20. Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy
21. Hypoglycemia possibly caused by CYP2C9-mediated drug interaction in combination with bucolome: a case report
22. Optimal teicoplanin dosing regimen in neonates and children developed by leveraging real-world clinical information
23. Profiles and Outcomes of Skin Injuries Caused by Injectable Drug Extravasation
24. Differences in Theophylline Clearance between Patients with Chronic Hepatitis and those with Liver Cirrhosis
25. Clinical Pharmacokinetics of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer
26. Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation
27. Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia
28. Improvement of Medication Guidance Sheet for Total Body Irradiation/Cyclophosphamide Followed by Allogeneic Hematopoietic Stem Cell Transplantation Based on Real Monitoring Data
29. Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide
30. Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP
31. The relationship between fine particulate matter (PM2.5) and schizophrenia severity
32. Population Pharmacokinetic Analysis of Phenytoin After Intravenous Administration of Fosphenytoin in Adult and Elderly Epileptic Patients
33. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion
34. Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study
35. Drug-related problems identified at a Japanese community pharmacy: a cross-sectional study
36. Isoniazid level and flu‐like symptoms during rifapentine‐based tuberculosis preventive therapy: A population pharmacokinetic analysis
37. Population Pharmacodynamic Analysis of Uric Acid–Lowering Effects of Febuxostat Based on Electronic Medical Records in Two Hospitals
38. Population pharmacokinetic–pharmacodynamic modeling and model-based prediction of docetaxel-induced neutropenia in Japanese patients with non-small cell lung cancer
39. Neuroprotective effects of ibudilast against tacrolimus induced neurotoxicity
40. Optimal Teicoplanin Dosing Regimen in Neonates and Children Developed by Leveraging Real-World Clinical Information
41. Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study
42. Impact of Genetic Polymorphisms in CYP2C9 and CYP2C19 on the Pharmacokinetics of Clinically Used Drugs
43. Characterization of ADME gene variation in 21 populations by exome sequencing
44. Food-drug Interaction of Tacrolimus with Pomelo, Ginger, and Turmeric Juice in Rats
45. Functional Significance of Genetic Polymorphisms in P-glycoprotein (MDR1, ABCB1) and Breast Cancer Resistance Protein (BCRP, ABCG2)
46. A Survey of GS1 Data Bar Displays on Ethical Drug Press through Package
47. Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child–Pugh and MELD scores
48. Development and Validation of A Liquid Chromatography–Tandem Mass Spectrometry Method to Simultaneously Measure Tacrolimus and Everolimus Concentrations in Kidney Allograft Biopsies After Kidney Transplantation
49. Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
50. Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.